NEUMODX EBV QUANT ASSAY
Device
Qiagen, LLC
Total Payments
$19,760
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $19,760 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $19,760 | 1 | 100.0% |
Top Doctors Receiving Payments for NEUMODX EBV QUANT ASSAY
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Cleveland, OH | $19,760 | 1 |
Ad
Manufacturing Companies
- Qiagen, LLC $19,760
Product Information
- Type Device
- Total Payments $19,760
- Total Doctors 0
- Transactions 1
About NEUMODX EBV QUANT ASSAY
NEUMODX EBV QUANT ASSAY is a device associated with $19,760 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Qiagen, LLC.
Payment data is available from 2022 to 2022. In 2022, $19,760 was paid across 1 transactions to 0 doctors.
The most common payment nature for NEUMODX EBV QUANT ASSAY is "Unspecified" ($19,760, 100.0% of total).